NCT00577278 A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan Status COMPLETED Phase PHASE2
NCT00574886 Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy Status COMPLETED Phase NA
NCT00574626 Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma Status COMPLETED Phase NA
NCT00574509 Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00574496 Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00572013 Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00569985 Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma Status COMPLETED Phase PHASE1
NCT00569309 Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma Status COMPLETED Phase NA
NCT00568815 Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE2
NCT00568607 Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT00566228 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Status COMPLETED Phase PHASE3
NCT00562978 Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00562380 AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT00562068 Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma Status UNKNOWN Phase PHASE1
NCT00561756 Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT00561418 Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma Status COMPLETED Phase PHASE1
NCT00561301 Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma Status UNKNOWN Phase PHASE2
NCT00559104 Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00559065 A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China Status COMPLETED Phase N/A
NCT00558675 A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy Status COMPLETED Phase PHASE1/PHASE2